Back to top anchor

News and media

All the latest news and media releases from the Health Research Council.
  • International Relationship Fund recipients

    Issue date:
    News

    The HRC is pleased to announce funding for four projects that aim to facilitate the development of research collaborations between New Zealand researchers and European Union colleagues.

  • Cultural focus could aid injury recovery

    Issue date:
    News
    Updating informational resources to address spiritual and mental wellbeing could help Pasifika people's recovery from spinal cord injuries, according to a study by AUT University student Tainafi Lefono.
  • New initiative for independent research organisations

    Issue date:
    Media Release
    Four of New Zealand's independent research organisations will receive a combined total of more than $27 million in funding through a new initiative.
  • Examining the effects of methadone exposure

    Issue date:
    Media Release

    A New Zealand study examining the neurodevelopmental effects on children exposed to methadone in the womb will begin in July after the Health Research Council of New Zealand (HRC) confirmed funding

  • Scholar awarded $1.2m for Huntington's project

    Issue date:
    Media Release
    Māori neuroscientist Dr Melanie Cheung has been awarded nearly $1.2 million in the HRC's 2014 funding round to slow the progression of Huntington's disease using Māori-focused brain training.
  • HRC Board Chair receives knighthood

    Issue date:
    News
    HRC Board Chair Sir Robert Stewart has been made a Knight Companion of the New Zealand Order of Merit for services to manufacturing and the community.
  • Applying for funding using HRC Gateway

    Issue date:
    News
    Looking at applying for funding in the HRC's upcoming funding round? Documentation on how to apply for funding using our new online submission system, HRC Gateway, is now available to download.
  • Muscle damage risk low from cholesterol drug

    Issue date:
    News
    Otago researchers have found there's very low risk of serious muscle damage in the general population from taking a widely used cholesterol-lowering drug.